Clinically significant placebo analgesic response in a pilot trial of botulinum B in patients with hand pain and carpal tunnel syndrome

Pain Medicine

Volumn 7, Issue 1, 2006, Pages 16-24

  Breuer, Brenda ^a   Sperber, Kevin ^b   Wallenstein, Sylvan ^c   Kiprovski, Kiril ^d   Calapa, Angela ^d   Snow, Barry ^d   Pappagallo, Marco ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Botulinum toxin B; Carpal tunnel syndrome; Discomfort; Pain; Quality of life

Indexed keywords

BOTULINUM TOXIN B; PLACEBO;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROMYOGRAPHY; EXPERIENCE; FOLLOW UP; HAND DISEASE; HAND MUSCLE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SKIN TINGLING; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; TELEPHONE; THENAR; TREATMENT OUTCOME; UNITED STATES;

ANALGESICS; BOTULINUM TOXINS; CARPAL TUNNEL SYNDROME; DOUBLE-BLIND METHOD; DYSSOMNIAS; ELECTROMYOGRAPHY; HAND; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERVIEWS; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; PLACEBOS; TREATMENT FAILURE;

EID: 33644782675     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00084.x     Document Type: Article

References (30)

1. O'Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev 2003;(1): CD003219.
2. Verdugo RJ, Salinas RS, Castillo J, Cea JG. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev 2003; (1): CD001552.
3. Katz JN, Simmons BP. Clinical practice. Carpal tunnel syndrome. N Engl J Med 2002;346 (23): 1807-12.
4. Michelsen H, Posner MA. Medical history of carpal tunnel syndrome. Hand Clin 2002;18 (2): 257-68.
5. Dodick DW. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: From bench to bedside. Headache 2003;43 (Suppl. 1): S25-33.
6. Winner P. Botulinum toxins in the treatment of migraine and tension-type headaches. Phys Med Rehabil Clin N Am 2003;14 (4): 885-99.
7. Difazio M, Jabbari B. A focused review of the use of botulinum toxins for low back pain. Clin J Pain 2002;18 (Suppl. 6): S155-62.
8. De Andres J, Cerda-Olmedo G, Valia JC, et al. Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain 2003;19 (4): 269-75.
9. Walker FO. Botulinum toxin therapy for cervical dystonia. Phys Med Rehabil Clin N Am 2003;14 (4): 749-66, vi.
10. Figgitt DP, Noble S. Botulinum toxin B: A review of its therapeutic potential in the management of cervical dystonia. Drugs 2002;62 (4): 705-22.
11. Binder WJ, Brin MF, Blitzer A, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon 2002;48 (5): 323-35.
12. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107 (1-2): 125-33.
13. Mosby's Drug Consult. Botulinum toxin. 2006. Available at: http://home.mdconsult.com/das/drug/view/34759358-2/1/514/ top?sid=240404246 (accessed January 24, 2006).
14. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23 (4): 345-56.
15. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94 (2): 149-58.
16. NIH Consensus Conference. Acupuncture. JAMA 1998;280 (17): 1518-24.
17. Naeser MA, Hahn KA, Lieberman BE, Branco KF. Carpal tunnel syndrome pain treated with low-level laser and microamperes transcutaneous electric nerve stimulation: A controlled study. Arch Phys Med Rehabil 2002;83 (7): 978-88.
18. David J, Modi S, Aluko AA, Robertshaw C, Farebrother J. Chronic neck pain: A comparison of acupuncture treatment and physiotherapy. Br J Rheumatol 1998;37 (10): 1118-22.
19. Speed CA. Injection therapies for soft-tissue disorders. Best Pract Res Cl Rh 2003;17 (1): 168-81.
20. Chu J. Does EMG (dry needling) reduce myofascial pain symptoms due to cervical nerve root irritation? Electromyogr Clin Neurophysiol 1997;37 (5): 259-72.
21. Baldry P. Management of myofascial trigger point pain. Acupunct Med 2002; 20 (1): 2-10.
22. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: A systematic review. Arch Phys Med Rehabil 2001;82 (7): 986-92.
23. Simons DG, Mense S. [Diagnosis and therapy of myofascial trigger points]. Schmerz 2003;17 (6): 419-24.
24. Figuerola ML, Loe W, Sormani M, Barontini M. Met-enkephalin increase in patients with fibromyalgia under local treatment. Funct Neurol 1998;13 (4): 291-5.
25. Chu J, Schwartz I. The muscle twitch in myofascial pain relief: Effects of acupuncture and other needling methods. Electromyogr Clin Neurophysiol 2002;42 (5): 307-11.
26. Hong CZ. Persistence of local twitch response with loss of conduction to and from the spinal cord. Arch Phys Med Rehabil 1994;75 (1): 12-6.
27. Chen JT, Chung KC, Hou CR, et al. Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 2001;80 (10): 729-35.
28. Chu J, Yuen KF, Wang BH, et al. Electrical twitch-obtaining intramuscular stimulation in lower back pain: A pilot study. Am J Phys Med Rehabil 2004;83 (2): 104-11.
29. Cohen-Mansfield J. Recruitment rates in gerontological research: The situation for drug trials in dementia may be worse than previously reported. Alzheimer Dis Assoc Disord 2002;16 (4): 279-82.
30. Manfredi P, Breuer B, Wallenstein S, et al. Opioid treatment for refractory agitation in patients with advanced dementia. Int J Geriatr Psychiatry 2003;18 (8): 700-5.